MedPath

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

389

Active:0
Completed:302

Trial Phases

6 Phases

Early Phase 1:3
Phase 1:109
Phase 2:130
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (313 trials with phase data)• Click on a phase to view related trials

Phase 2
130 (41.5%)
Phase 1
109 (34.8%)
Not Applicable
39 (12.5%)
Phase 4
17 (5.4%)
Phase 3
15 (4.8%)
Early Phase 1
3 (1.0%)

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Not yet recruiting
Conditions
Substance Use Disorders (SUDs)
First Posted Date
2025-05-30
Last Posted Date
2025-07-10
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
30
Registration Number
NCT06995885
Locations
🇺🇸

National Institute on Drug Abuse, Baltimore, Maryland, United States

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Phase 1
Not yet recruiting
Conditions
Healthy Volunteers
First Posted Date
2025-03-11
Last Posted Date
2025-07-10
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
35
Registration Number
NCT06868914
Locations
🇺🇸

National Institute on Drug Abuse, Baltimore, Maryland, United States

Environment and Alcohol: A Pilot Study

Phase 1
Recruiting
Conditions
Alcohol Use Disorder
First Posted Date
2025-03-06
Last Posted Date
2025-07-10
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
44
Registration Number
NCT06860607
Locations
🇺🇸

National Institute on Drug Abuse, Baltimore, Maryland, United States

VK4-116 Phase I Study With Food-Effect

Phase 1
Not yet recruiting
Conditions
Opioid Dependence
Opioid Use Disorder (OUD)
Interventions
Drug: Placebo
First Posted Date
2025-02-05
Last Posted Date
2025-05-22
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
48
Registration Number
NCT06808932
Locations
🇺🇸

Altasciences Clinical Kansas, Overland Park, Kansas, United States

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Recruiting
Conditions
Alcoholism
Substance-Related Disorders
First Posted Date
2024-11-06
Last Posted Date
2025-07-10
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
10000
Registration Number
NCT06676059
Locations
🇺🇸

National Institute on Drug Abuse, Baltimore, Maryland, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 78
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath